Insights

Recent Acquisition Zimmer Biomet's acquisition of EmCyte Corporation in March 2023 indicates a strategic integration of autologous biologic technologies, offering potential upselling opportunities for enhanced regenerative medicine solutions and collaboration on high-value device sales.

Regulatory Milestones EmCyte's FDA 510(k) clearances for its PurePRP and Progenikine systems demonstrate regulatory credibility and market readiness, presenting opportunities to pitch these established, compliant products to clinics seeking proven biologics solutions.

Innovation Leadership With over 20 years of experience and a focus on cutting-edge autologous biologics, EmCyte is well-positioned to expand its product offerings, creating openings for sales of new, innovative devices to medical practices invested in advanced regenerative treatments.

Educational Collaborations Partnerships with organizations like Konica Minolta highlight EmCyte’s active engagement in training and advancing ultrasound-guided biologic procedures, providing sales avenues for educational packages, workshops, and related device integrations.

Growth Market Operating within the fast-growing regenerative medicine industry with a focus on platelet-rich plasma and stem cell biologics, EmCyte presents multiple opportunities to introduce complementary products and expand into emerging clinical markets.

EMCYTE CORP. Tech Stack

EMCYTE CORP. uses 8 technology products and services including BoldGrid, Open Graph, MySQL, and more. Explore EMCYTE CORP.'s tech stack below.

  • BoldGrid
    Content Management System
  • Open Graph
    Content Management System
  • MySQL
    Database
  • Punycode
    Font Scripts
  • SweetAlert2
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Animate.css
    UI Frameworks

EMCYTE CORP.'s Email Address Formats

EMCYTE CORP. uses at least 1 format(s):
EMCYTE CORP. Email FormatsExamplePercentage
First@emcyte.comJohn@emcyte.com
50%
First@emcyte.comJohn@emcyte.com
50%

Frequently Asked Questions

Where is EMCYTE CORP.'s headquarters located?

Minus sign iconPlus sign icon
EMCYTE CORP.'s main headquarters is located at 4331 Veronica South Shoemaker Boulevard Suite 4 Fort Myers, Florida 33916 United States. The company has employees across 1 continents, including North America.

What is EMCYTE CORP.'s phone number?

Minus sign iconPlus sign icon
You can contact EMCYTE CORP.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is EMCYTE CORP.'s official website and social media links?

Minus sign iconPlus sign icon
EMCYTE CORP.'s official website is emcyte.com and has social profiles on LinkedIn.

What is EMCYTE CORP.'s SIC code NAICS code?

Minus sign iconPlus sign icon
EMCYTE CORP.'s SIC code is 7389 - Business Services, Not Elsewhere Classified NAICS code is 3261 - Plastics Product Manufacturing.

How many employees does EMCYTE CORP. have currently?

Minus sign iconPlus sign icon
As of February 2026, EMCYTE CORP. has approximately 19 employees across 1 continents, including North America. Key team members include Chief Scientific Officer: L. E.Founder, President & Ceo: P. P.Clinical Director, Vp Sales: M. J.. Explore EMCYTE CORP.'s employee directory with LeadIQ.

What industry does EMCYTE CORP. belong to?

Minus sign iconPlus sign icon
EMCYTE CORP. operates in the Medical Equipment Manufacturing industry.

What technology does EMCYTE CORP. use?

Minus sign iconPlus sign icon
EMCYTE CORP.'s tech stack includes BoldGridOpen GraphMySQLPunycodeSweetAlert2jQuery MigrateModernizrAnimate.css.

What is EMCYTE CORP.'s email format?

Minus sign iconPlus sign icon
EMCYTE CORP.'s email format typically follows the pattern of First@emcyte.com. Find more EMCYTE CORP. email formats with LeadIQ.

When was EMCYTE CORP. founded?

Minus sign iconPlus sign icon
EMCYTE CORP. was founded in 2000.

EMCYTE CORP.

Medical Equipment ManufacturingFlorida, United States11-50 Employees

As the leader in Autologous Biologics, EmCyte Corporation® delivers cutting-edge technology that supports evidence-based treatment methodology in the emerging field of regenerative medicine.  

Our product portfolio meets the highest achievable performance standards at the point of care and contains innovation that improves clinical outcomes for patients around the globe. Offering more power, versatility, efficiency, and quality at the point of care,  

EmCyte Corporation® is committed to the continual development and improvement of devices used for autologous regenerative biologics and to the promotion of autologous therapies used to enhance the quality of life.

Our devices are cleared for marketing through both CDRH and CEBR divisions of the FDA, under 510(k) BK050055, K070666, K024080, K183205, and now K191564.  

EmCyte Corporation® has more than 20 years of medical device manufacturing experience, delivering excellence to its customers. 

At our headquarters in Fort Myers, Florida, we use state-of-the-art manufacturing equipment in a modernized facility housing certified clean rooms to deliver products with the highest safety and quality standards.  Our reliable and efficient assembly and packaging operations allow us to develop various custom projects for dedicated customers.

Section iconCompany Overview

Headquarters
4331 Veronica South Shoemaker Boulevard Suite 4 Fort Myers, Florida 33916 United States
Phone number
Website
emcyte.com
SIC Code
7389 - Business Services, Not Elsewhere Classified
NAICS Code
3261 - Plastics Product Manufacturing
Founded
2000
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    EMCYTE CORP.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    EMCYTE CORP.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.